Alaunos Therapeutics, Inc. (TCRT)
1.50
-0.06
(-3.85%)
USD |
NASDAQ |
Sep 10, 16:00
1.50
0.00 (0.00%)
After-Hours: 20:00
Alaunos Therapeutics Total Liabilities (Quarterly) : 0.864M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.864M |
| March 31, 2026 | 0.595M |
| December 31, 2025 | 0.813M |
| September 30, 2025 | 0.921M |
| June 30, 2025 | 1.074M |
| March 31, 2025 | 1.062M |
| December 31, 2024 | 0.692M |
| September 30, 2024 | 0.826M |
| June 30, 2024 | 0.907M |
| March 31, 2024 | 1.24M |
| December 31, 2023 | 1.956M |
| September 30, 2023 | 5.54M |
| June 30, 2023 | 6.277M |
| March 31, 2023 | 19.13M |
| December 31, 2022 | 26.38M |
| September 30, 2022 | 35.23M |
| June 30, 2022 | 33.75M |
| March 31, 2022 | 35.87M |
| December 31, 2021 | 36.81M |
| September 30, 2021 | 45.06M |
| June 30, 2021 | 18.48M |
| March 31, 2021 | 22.83M |
| December 31, 2020 | 22.36M |
| September 30, 2020 | 20.98M |
| June 30, 2020 | 18.26M |
| Date | Value |
|---|---|
| March 31, 2020 | 17.94M |
| December 31, 2019 | 14.10M |
| September 30, 2019 | 11.82M |
| June 30, 2019 | 11.18M |
| March 31, 2019 | 9.287M |
| December 31, 2018 | 9.487M |
| September 30, 2018 | 62.79M |
| June 30, 2018 | 61.19M |
| March 31, 2018 | 61.57M |
| December 31, 2017 | 58.42M |
| September 30, 2017 | 57.29M |
| June 30, 2017 | 56.85M |
| March 31, 2017 | 59.96M |
| December 31, 2016 | 58.32M |
| September 30, 2016 | 59.73M |
| June 30, 2016 | 180.00M |
| March 31, 2016 | 63.87M |
| December 31, 2015 | 66.35M |
| September 30, 2015 | 79.52M |
| June 30, 2015 | 13.60M |
| March 31, 2015 | 11.04M |
| December 31, 2014 | 11.40M |
| September 30, 2014 | 12.63M |
| June 30, 2014 | 17.63M |
| March 31, 2014 | 21.59M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
| Imunon, Inc. | 10.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.516M |
| Shareholders Equity (Quarterly) | 0.652M |
| Current Ratio | 0.7708 |